“Dr. Schwartz is a rising star [in] the NIH community,” says Ms. Biehl. “She is a fantastic teacher and collaborator.”
Psoriatic arthritis affects up to 20% of people with psoriasis and, if left untreated, can cause severe joint destruction. The condition is also less responsive to medications approved by the U.S. Food & Drug Administration than psoriatic skin disease.
This session will touch on identifying various presentations of psoriatic arthritis in patients with different types of psoriatic skin disease, says Ms. Biehl. Dr. Schwartz will wrap up with a discussion of treatment options and a review of the extra-articular comorbidities of patients with psoriatic arthritis and associated screening guidelines.
Each speaker will hold a five-minute question-and-answer period following their presentations. Here are the dates and times of all four sessions:
- Sunday, Nov. 8, 10–10:30 a.m. EST
Down & Dirty 30: Therapeutic Exercise for Bone Health - Sunday, Nov. 8, 10:45–11:15 a.m. EST
Down & Dirty 30: Therapeutic Exercise for Joint Health - Sunday, Nov. 8, 3–3:30 p.m. EST
Down & Dirty 30: Rheumatoid Arthritis from Diagnosis to Treatment - Sunday, Nov. 8, 3:45 p.m.–4:15 p.m. EST
Down & Dirty 30: Psoriatic Arthritis
Catherine Kolonko is a medical writer based in Oregon.
